Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage
- PMID: 31434095
- DOI: 10.1159/000502507
Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage
Abstract
Introduction: Hemodialysis (HD) in end-stage renal disease (ESRD) patients requires vascular access (VA) through an arteriovenous fistula (AVF), a prosthetic arteriovenous graft (AVG), or a central venous catheter. While AVF or AVG is commonly used for HD, the economic implications of AVF versus AVG use have not been fully established. We describe the healthcare resource utilization and costs of AVF and AVG use for incident ESRD patients in the United States.
Methods: This observational cohort study of AVF and AVG placements used data from the United States Renal Data System to identify and follow access placements. AVF and AVG placements after ESRD onset for incident patients from 2012 to 2014 with continuous Medicare primary coverage were included. All-cause and access-related Medicare costs were averaged over the placement lifetime and expressed as per dialysis-month costs.
Results: The analysis included 38,035 AVF placements and 12,789 AVG placements. Total all-cause monthly costs for AVF averaged USD 8,508; mean monthly costs were USD 3,027 for inpatient (IP), USD 3,139 for outpatient (OP), USD 1,572 for physician services, and USD 770 for other care settings. Access-related monthly costs averaged USD 1,699 and represented 20% of all-cause charges for AVFs. Mean all-cause monthly costs for AVG were USD 9,605; by setting monthly costs were USD 3,811 for IP, USD 3,034 for OP, USD 1,881 for physician services and USD 879 for other care settings. Access-related monthly costs averaged USD 2,656 and represented 28% of all-cause charges for AVGs.
Discussion/conclusions: This study indicates that costs due to VA are a significant burden on Medicare budgets and on patients. The factors driving access-related utilization and costs merit attention in future research. Both optimizing process of care and discovery innovation may significantly accelerate better stewardship of available healthcare resources.
Keywords: Arteriovenous fistula; Arteriovenous graft; Health economics; Healthcare costs; Hemodialysis; Vascular access.
© 2019 S. Karger AG, Basel.
Similar articles
-
Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.Am J Nephrol. 2019;49(2):156-164. doi: 10.1159/000495355. Epub 2019 Jan 24. Am J Nephrol. 2019. PMID: 30677763
-
Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.Am J Kidney Dis. 2018 Jul;72(1):10-18. doi: 10.1053/j.ajkd.2018.01.034. Epub 2018 Mar 28. Am J Kidney Dis. 2018. PMID: 29602630
-
Catheter Dependence After Arteriovenous Fistula or Graft Placement Among Elderly Patients on Hemodialysis.Am J Kidney Dis. 2021 Sep;78(3):399-408.e1. doi: 10.1053/j.ajkd.2020.12.019. Epub 2021 Feb 12. Am J Kidney Dis. 2021. PMID: 33582176
-
Vascular Access for Hemodialysis Patients: New Data Should Guide Decision Making.Clin J Am Soc Nephrol. 2019 Jun 7;14(6):954-961. doi: 10.2215/CJN.00490119. Epub 2019 Apr 11. Clin J Am Soc Nephrol. 2019. PMID: 30975657 Free PMC article. Review.
-
Gender differences in vascular access in hemodialysis patients in the United States: developing strategies for improving access outcome.Gend Med. 2007 Sep;4(3):193-204. doi: 10.1016/s1550-8579(07)80040-4. Gend Med. 2007. PMID: 18022587 Review.
Cited by
-
Machine learning-based prediction model for arteriovenous fistula thrombosis risk: a retrospective cohort study from 2017 to 2024.BMC Nephrol. 2025 Jul 1;26(1):304. doi: 10.1186/s12882-025-04201-4. BMC Nephrol. 2025. PMID: 40597021 Free PMC article.
-
IN.PACT AV Access Trial: Economic Evaluation of Drug-Coated Balloon Treatment for Dysfunctional Arteriovenous Fistulae Based on 12-Month Clinical Outcomes.J Vasc Interv Radiol. 2022 Aug;33(8):895-902.e4. doi: 10.1016/j.jvir.2022.04.014. Epub 2022 Apr 25. J Vasc Interv Radiol. 2022. PMID: 35472578 Free PMC article. Clinical Trial.
-
Cost-Effectiveness of Drug-Coated Balloon Angioplasty versus Plain Old Balloon Angioplasty for Arteriovenous Fistula Stenosis.Cardiovasc Intervent Radiol. 2023 Sep;46(9):1221-1230. doi: 10.1007/s00270-023-03403-3. Epub 2023 Mar 28. Cardiovasc Intervent Radiol. 2023. PMID: 36977902
-
Assessment of photobiomodulation in response to the microcirculation in arteriovenous fistula for hemodialysis patient.Asian Biomed (Res Rev News). 2025 Feb 28;19(1):3-13. doi: 10.2478/abm-2025-0005. eCollection 2025 Feb. Asian Biomed (Res Rev News). 2025. PMID: 40231166 Free PMC article.
-
Potential implications of blood flow restriction exercise on patients with chronic kidney disease: a brief review.J Exerc Rehabil. 2022 Apr 26;18(2):81-95. doi: 10.12965/jer.2244082.041. eCollection 2022 Apr. J Exerc Rehabil. 2022. PMID: 35582687 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous